NCI ETCTN Lead Academic Organization grants to run early phase experimental therapy trials
The National Cancer Institute is inviting eligible institutions to apply to become Lead Academic Organizations (LAOs) for its Experimental Therapeutics Clinical Trials Network (ETCTN). LAOs will design, manage, conduct, and analyze early phase experimental therapeutic clinical trials (including phase 0–2 and pilot studies) for NCI-related investigational drugs under IND sponsorship. The same L…
Source
Award
Eligibility
Keywords
Supporting Links
Documents
Similar Opportunities
Get the full picture on this opportunity
Create a free Scout account to unlock everything you need to decide fast and win the grant.
-
Instant Fit Analysis
Let our grant expert AI score how well this opportunity aligns with your organization, strengths, gaps, and how to improve your chances of winning funding.
-
Deep agency & funder detail
Program context, sub-agency structure, and a full eligibility breakdown.
-
Source links & full documents
Jump straight to the solicitation and download every attachment.
-
Similar opportunities
Discover related funding matched to your work.
Already have an account? Sign In
Trusted by 500+ Happy Customers